Restoration of expression of transforming growth factor-β Type II receptor in murine renal cell carcinoma (renca) cells by 5-Aza-2′- deoxycytidine

Life Sciences

Volumn 76, Issue 10, 2005, Pages 1159-1166

  Zhang, Qiang ^a   Rubenstein, Jonathan N ^a   Liu, Victoria C ^a   Park, Irwin ^a   Jang, Thomas ^a   Lee, Chung ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Promoter methylation; Renal cell carcinoma; TGF receptors; TGF Signaling

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; RECEPTOR SUBTYPE; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; DNA METHYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; KIDNEY CARCINOMA; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; DNA METHYLATION; KIDNEY NEOPLASMS; MICE; PROMOTER REGIONS (GENETICS); RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

MURINAE;

EID: 11144314306     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.10.021     Document Type: Article

References (25)

1. K. Park, S.J. Kim, Y.J. Bang, J.G. Park, N.K. Kim, A.B. Roberts, and M.B. Sporn Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β Proceedings of the National Academy of Sciences 91 19 1994 8772 8776
2. L.Z. Sun, G. Wu, J.K.V. Wilson, E. Zbrowska, J. Yang, I. Rajkarunanayake, J. Wang, L.E. Gentry, X.F. Wang, and M.G. Brittain Expression of transforming growth factor β type I receport leads to reduced malignancy in human breast cancer MCF-7 cells Journal of Biological Chemistry 269 42 1994 26449 26455
3. S. Markowitz, J. Wang, L. Meyeroff, R. Parsons, L. Sun, J. Lutterbaugh, R.S. Fan, E. Zbrowska, K.W. Kinzler, B.M. Vogelstein, M. Brattain, and J.K.V. Willson Inactivation of the type II TGF-β receptor in colon cancer cells with microsattelite instability Science 268 5215 1995 1336 1338
4. L. Garrigue-Antar, T. Nunoz-Zntonia, S.J. Antonia, J. Gesmonde, V.F. Velluci, and M. Reiss Missense mutations of the transforming growth factor β type II receptor in human head and neck squamos carcinoma cells Cancer Research 55 18 1995 3982 3987
5. E. Kalkhoven, B.A.J. Roelen, J.P. de Winter, C.L. Mummerym, A.J.M. van den Eijnden-van Raaij, P.T. van der Saag, and B. van der Burg Resistance to transforming growth factor β and activin due to reduced receptor expression in human breast cancer cell lines Cell Growth Differentiation 6 9 1995 1151 1161
6. J. Wang, L.Z. Sun, L. Myeroff, X. Wang, L.E. Gentry, J. Yang, J. Liang, E. Zborowska, S. Markowitz, J.K.V. Willson, and M.G. Brattain Demonstration that mutation of type II TGF-β receptor inactivates its tumor suppressor in replication error-positive colon carcinoma cells Journal of Biological Chemistry 270 37 1995 22044 22049
7. S.K. Gregorian, and J.R. Battisto Immunosuppression in murine renal cell carcinoma Cancer immunology, immunotherapy 31 6 1990 325 334
8. P.D. Williams, E.J. Pontes, and G.P. Murphy Studies on the growth of a murine renal cell carcinoma and its metastic patterns Research Commun Chemistry Pathology Pharmacolgy 34 2 1981 345 349
9. S. Kundu, I.Y. Kim, D. Zelner, L. Janulis, S. Goodwin, J. Engel, and C. Lee Absence of expression of transforming growth factor-β type II receptor is associated with an aggressive growth pattern in a murine renal carcinoma cell line, Renca Journal of Urology 160 5 1998 1883 1888
10. J.D. Engel, S.D. Kundu, T. Yang, S. Lang, S. Goodwin, L. Janulis, J. Chang, S.J. Kim, and C. Lee Transforming growth factor-β type II receptor confers tumor suppressor activity in murine renal carcinoma (Renca) cells Urology 54 1 1999 164 170
11. P.A. Jones, and S.B. Baylin The fundamental role of epigenetic events in cancer Nature Reviews: Genetics 3 6 2002 415 428
12. A.P. Feinberg Cancer epigenetics takes center stage Proceedings of the National Academy of Sciences 98 2 2001 392 394
13. Z.M. Gonzalez, C.M. Bender, A.S. Yang, T. Nguyen, R.W. Beart, J.M. Van Tornout, and P.A. Jones Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing Cancer Research 55 20 1995 4531 4535
14. A. Merlo, J.G. Herman, L. Mao, D.J. Lee, E. Gabrielson, P.C. Burger, S.B. Baylin, and D. Sidransky 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers Nature Medicine 1 7 1995 686 692
15. K.D. Robertson, and P.A. Jones The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53 Molecular Cell Biology 18 11 1998 6457 6473
16. C.T. Nguyen, F.A. Gonzales, and P.A. Jones Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation. MeCP2 binding and acetylation Nucleic Acids Research 29 22 2001 4598 4606
17. M. Hanada, D. Delia, A. Aiello, E. Stadtmauer, and J.C. Reed Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia Blood 82 6 1993 1820 1828
18. A.P. Feinberg, and B. Vogelstein Hypomethylation distinguishes genes of some human cancers from their normal counterparts Nature 301 5895 1983 89 92
19. C.T. Nguyen, D.J. Weisenberger, M. Velicescu, F.A. Gonzales, J.C. Lin, G. Liang, and P.A. Jones Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine Cancer Research 62 22 2002 6456 6461
20. K.O. Toyooka, S. Toyooka, A.K. Virmani, U.G. Sathyanarayana, D.M. Euhus, M. Gilcrease, J.D. Minna, and A.F. Gazdar Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas Cancer Research 61 1 2001 4556 4560
21. M. Sato, Y. Mori, A. Sakurada, S. Fujimura, and A. Horii The H-cadherin (CDH13) gene is inactivated in human lung cancer Human. Genetics 103 1 1998 96 101
22. M. Kawakami, J. Staub, W. Cliby, L. Hartmann, D.I. Smith, and V. Shridhar Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer International Journal of Oncology 15 4 1999 715 720
23. S. Toyooka, O.K. Toyooka, R. Maruyama, A.K. Virmani, L. Girard, K. Miyajima, K. Harada, Y. Ariyoshi, T. Takahashi, K. Sugio, E. Brambilla, M. Gilcrease, J.D. Minna, and A.F. Gazdar DNA methylation profiles of lung tumors Molecular Cancer Therapeutics 1 1 2001 61 67
24. R. Maruyama, S. Toyooka, K.O. Toyooka, K. Harada, A.K. Virmani, M.S. Zochbauer, A.J. Farinas, L.F. Vakar, J.D. Minna, A. Sagalowsky, B. Czerniak, and A.F. Gazdar Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features Cancer Research 61 24 2001 8659 8663
25. R. Maruyama, S. Toyooka, K.O. Toyooka, A.K. Virmani, M.S. Zochbauer, A.J. Farinas, J.D. Minna, J. McConnell, E.P. Frenkel, and A.F. Gazdar Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features Clinical Cancer Research 8 2 2002 514 519